Pomalidomide is a derivative of thalidomide. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide has been approved on February 28, 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.
Product Name: Pomalidomide
CAS Number: 19171-19-8
Molecular Weight:  273.2476
Molecular Formula:  C13H11N3O4
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.
- Brands Tenova Pharmaceuticals
- Product Code: T31072
- Availability: In Stock
- Ex Tax: $277.00